Recent years have seen growing interest in the use of artificial intelligence tools for healthcare applications, including diagnosis, risk prediction,…
Pathalys Pharma, the Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new…
Gene therapy company Asklepios BioPharmaceutical (AskBio) of Research Triangle Park has signed a multi-year research collaboration and option agreement with…